HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
155427.0,246871,2117-11-26 06:26:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Pretransplant Workup Started.
   - Liver following, recommended transplant work up.
   - started on NAC
   - charcoal 30- 50gm q12 hrs
   - watch out for seizure with high dose penicillin
   - 120mg/kg divided q 6 hrs.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 04:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2117-11-25**] 03:30 PM
   Famotidine (Pepcid) - [**2117-11-25**] 03:30 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2117-11-26**] 06:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37.3
C (99.2
   HR: 98 (88 - 144) bpm
   BP: 150/82(97) {131/70(90) - 175/102(114)} mmHg
   RR: 15 (12 - 20) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  2,211 mL
                                                                  2,914 mL
   PO:
             120 mL
   TF:
   IVF:
                                                                  2,211 mL
                                                                  2,794 mL
   Blood products:
   Total out:
                                                                  2,050 mL
                                                                  1,450 mL
   Urine:
                                                                    200 mL
                                                                    450 mL
   NG:
                                                                    250 mL
   Stool:
                                                                  1,600 mL
                                                                  1,000 mL
   Drains:
   Balance:
                                                                    161 mL
                                                                  1,464 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///20/
   Physical Examination
   Cardiovascular: Gen: NAD
   CV: RRR, tachycardic
   Lungs: CTAB
   Abd: soft, minimally tender, ABS
   Ext: no c/c/e
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   240 K/uL
   13.6 g/dL
   149 mg/dL
   0.9 mg/dL
   20 mEq/L
   4.0 mEq/L
   17 mg/dL
   115 mEq/L
   147 mEq/L
   40.8 %
   12.1 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
   WBC
   13.2
   12.1
   Hct
   43.3
   40.8
   Plt
   286
   240
   Cr
   0.9
   0.9
   Glucose
   135
   149
   Other labs: PT / PTT / INR:14.1/27.2/1.2, ALT / AST:1280/1109, Alk Phos
   / T Bili:38/0.8, Amylase / Lipase:13/25, Differential-Neuts:90.6 %,
   Lymph:6.5 %, Mono:2.3 %, Eos:0.3 %, Albumin:4.9 g/dL, LDH:1173 IU/L,
   Ca++:9.1 mg/dL, Mg++:2.2 mg/dL, PO4:3.0 mg/dL
   Imaging: none
   Microbiology: pre liver transplant workup pending
   Assessment and Plan
 ANXIETY
 HEPATITIS, ACUTE TOXIC (INCLUDING ALCOHOLIC, ACETAMINOPHEN, ETC.)
 POISONING / OVERDOSE, OTHER
   mushroom ingestion poisoning
 IMPAIRED HEALTH MAINTENANCE
 LIVER FUNCTION ABNORMALITIES
 TACHYCARDIA, OTHER
   45 yo M with h/o HTN, HL, presents with N/V/D and LFT abnormalities
   after mushroom ingestion.
   .
   #. Mushroom ingestion:  Pt doing poorly with rapidly rising LFTs.  Will
   likely need liver transplant.  Currently undergoing supportive
   management.  Not significant data on treatment for Amanita Phalloides
   ingestion.
   - 1) Activated Charcoal - 1 dose at home and 2 doses in ED.  Restarted
   at q12 hrs.
     2) NAC - 100mg/kg over 16hrs (stage 2), to be followed by Stage 3 of
   NAC protocol
     3) PEN G 500,000U/kg over 24hrs (6 doses every 4hrs), watch for
   seizure activity
     4) Milk Thistle 1250mg tid
     5) Cimetedine 3gm IV q 6 hrs, - Annals of Emergency Medicine [**2115**];
   50;282-288.  Rsp [**2116-9-11**];52;184
   - f/u toxicology recs, appreciate input
   - f/u Liver
   - call Tranplant early to see him
   - Pretranplant workup started
   .
   #. Tachycardia/Hypertension:
   - IVF, NS running as fast as possible through limited access
   - consider restarting home medication if hypertension becoming
   concerning
   FEN: NPO for now, lytes prn, IVF fluids
   .
   PPX:
   -DVT ppx with heparin SC
   -Bowel regimen - having active diarrhea
   -Pain management with none
   - Antiemetics prn
   -FI with H2Blocker
   .
   ACCESS: PIV's, will need more access if going to continue with IVF or
   further tx required.
   .
   CODE STATUS: confirmed full
   .
   EMERGENCY CONTACT: wife
   .
   DISPOSITION: ICU
   .
   .
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary:
The patient is a 45-year-old male with a history of hypertension and hyperlipidemia who presents with nausea, vomiting, diarrhea, and liver function abnormalities after mushroom ingestion. He is currently undergoing supportive management in the ICU. The patient has been given activated charcoal, N-acetylcysteine (NAC), penicillin G, and milk thistle. He also received cimetidine. The patient's vital signs are stable, with a temperature of 37.3 degrees Celsius, heart rate of 98 beats per minute, blood pressure of 150/82 mmHg, respiratory rate of 15 breaths per minute, and oxygen saturation of 96% on a nasal cannula. His hemodynamic monitoring, fluid balance, and respiratory support are being closely monitored. The patient's laboratory results show elevated white blood cell count, hematocrit, platelet count, liver enzymes, and liver function tests. Imaging and microbiology studies are pending. The patient is planned for a liver transplant due to suspected acute toxic hepatitis from mushroom ingestion.

Potential Medical Complications:
1. Seizure activity due to high dose penicillin G.
2. Infection due to immunosuppression from liver failure and potential transpl"
155427.0,246871,2117-11-26 06:26:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Pretransplant Workup Started.
   - Liver following, recommended transplant work up.
   - started on NAC
   - charcoal 30- 50gm q12 hrs
   - high dose cimetidine
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 04:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2117-11-25**] 03:30 PM
   Famotidine (Pepcid) - [**2117-11-25**] 03:30 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2117-11-26**] 06:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37.3
C (99.2
   HR: 98 (88 - 144) bpm
   BP: 150/82(97) {131/70(90) - 175/102(114)} mmHg
   RR: 15 (12 - 20) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  2,211 mL
                                                                  2,914 mL
   PO:
             120 mL
   TF:
   IVF:
                                                                  2,211 mL
                                                                  2,794 mL
   Blood products:
   Total out:
                                                                  2,050 mL
                                                                  1,450 mL
   Urine:
                                                                    200 mL
                                                                    450 mL
   NG:
                                                                    250 mL
   Stool:
                                                                  1,600 mL
                                                                  1,000 mL
   Drains:
   Balance:
                                                                    161 mL
                                                                  1,464 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///20/
   Physical Examination
   Cardiovascular: Gen: NAD
   CV: RRR, tachycardic
   Lungs: CTAB
   Abd: soft, minimally tender, ABS
   Ext: no c/c/e
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   240 K/uL
   13.6 g/dL
   149 mg/dL
   0.9 mg/dL
   20 mEq/L
   4.0 mEq/L
   17 mg/dL
   115 mEq/L
   147 mEq/L
   40.8 %
   12.1 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
   WBC
   13.2
   12.1
   Hct
   43.3
   40.8
   Plt
   286
   240
   Cr
   0.9
   0.9
   Glucose
   135
   149
   Other labs: PT / PTT / INR:14.1/27.2/1.2, ALT / AST:1280/1109, Alk Phos
   / T Bili:38/0.8, Amylase / Lipase:13/25, Differential-Neuts:90.6 %,
   Lymph:6.5 %, Mono:2.3 %, Eos:0.3 %, Albumin:4.9 g/dL, LDH:1173 IU/L,
   Ca++:9.1 mg/dL, Mg++:2.2 mg/dL, PO4:3.0 mg/dL
   Imaging: none
   Microbiology: pre liver transplant workup pending
   Assessment and Plan
 ANXIETY
 HEPATITIS, ACUTE TOXIC (INCLUDING ALCOHOLIC, ACETAMINOPHEN, ETC.)
 POISONING / OVERDOSE, OTHER
   mushroom ingestion poisoning
 IMPAIRED HEALTH MAINTENANCE
 LIVER FUNCTION ABNORMALITIES
 TACHYCARDIA, OTHER
   45 yo M with h/o HTN, HL, presents with N/V/D and LFT abnormalities
   after mushroom ingestion.
   .
   #. Mushroom ingestion:  Pt doing poorly with rapidly rising LFTs.  Will
   likely need liver transplant.  Currently undergoing supportive
   management.  Not significant data on treatment for Amanita Phalloides
   ingestion.
   - 1) Activated Charcoal - 1 dose at home and 2 doses in ED.  Restarted
   at q12 hrs.
     2) NAC - 100mg/kg over 16hrs (stage 2), to be followed by Stage 3 of
   NAC protocol
     3) PEN G 500,000U/kg over 24hrs (6 doses every 4hrs), watch for
   seizure activity
     4) Milk Thistle 1250mg tid
     5) Cimetedine 3gm IV q 6 hrs, - Annals of Emergency Medicine [**2115**];
   50;282-288.  Rsp [**2116-9-11**];52;184
   - f/u toxicology recs, appreciate input, particularly regarding course
   of high dose medications, inform pharmacy so they are able to obtain
   enough medication.
   - f/u Liver
   - call Tranplant early to see him
   - Pretranplant workup started
   - try to get Silamarin (active compound in Milk Thistle)  as traetment
   .
   #. Tachycardia/Hypertension:
   - IVF, NS running as fast as possible through limited access
   - consider restarting home medication if hypertension becoming
   concerning
   FEN: NPO for now, lytes prn, IVF fluids
   .
   PPX:
   -DVT ppx with heparin SC
   -Bowel regimen - having active diarrhea
   -Pain management with none
   - Antiemetics prn
   -FI with H2Blocker
   .
   ACCESS: PIV's, Obtain PICC
   .
   CODE STATUS: confirmed full
   .
   EMERGENCY CONTACT: wife
   .
   DISPOSITION: ICU
   .
   .
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary:
- The patient is a 45-year-old male with a history of hypertension and hyperlipidemia.
- He presents with nausea, vomiting, diarrhea, and abnormal liver function tests after mushroom ingestion.
- The patient's condition is deteriorating rapidly, with worsening liver function tests.
- He is currently undergoing supportive management and is being considered for a liver transplant.
- The patient has no known drug allergies.
- His vital signs include a temperature of 37.3°C (99.2°F), heart rate of 98 bpm, blood pressure of 150/82 mmHg, respiratory rate of 15 breaths per minute, and oxygen saturation of 96% on a nasal cannula.
- The patient is tachycardic and has elevated blood pressure.
- His fluid balance shows an intake of 2,211 mL and output of 2,050 mL since midnight.
- The patient has received activated charcoal, N-acetylcysteine (NAC), penicillin G, and milk thistle.
- The patient is not eating and his pain is being managed with none.
- He has been placed on prophylactic measures including DVT prevention, stress ulcer prophylaxis, and VAP prevention.
- The patient's code status is full code and he is currently in the ICU.

Potential Medical Complications:
1. Liver Failure: The patient's presentation and lab results indicate acute liver toxicity, which may progress to liver failure. This can"
155427.0,246871,2117-11-26 08:52:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Liver Failure secondary to mushroom ingestion
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Diarrhea overnight, nausea
   24 Hour Events:
   Mushrooms ingested identified as amanita
   Transaminase continue to rise
   History obtained from [**Hospital 15**] Medical records, icu team
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 04:40 AM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2117-11-25**] 03:30 PM
   Heparin Sodium (Prophylaxis) - [**2117-11-25**] 03:30 PM
   Other medications:
   per ICU resident note
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever
   Cardiovascular: No(t) Chest pain.  Tachycardia
   Respiratory: No(t) Dyspnea
   Gastrointestinal: Nausea, Diarrhea
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2117-11-26**] 08:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37.3
C (99.2
   HR: 97 (88 - 144) bpm
   BP: 142/85(99) {131/70(90) - 175/102(114)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  2,211 mL
                                                                  3,870 mL
   PO:
             120 mL
   TF:
   IVF:
                                                                  2,211 mL
                                                                  3,750 mL
   Blood products:
   Total out:
                                                                  2,050 mL
                                                                  1,450 mL
   Urine:
                                                                    200 mL
                                                                    450 mL
   NG:
                                                                    250 mL
   Stool:
                                                                  1,600 mL
                                                                  1,000 mL
   Drains:
   Balance:
                                                                    161 mL
                                                                  2,420 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///20/
   Physical Examination
   General Appearance: No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed, plea
   Labs / Radiology
   13.6 g/dL
   240 K/uL
   149 mg/dL
   0.9 mg/dL
   20 mEq/L
   4.0 mEq/L
   17 mg/dL
   115 mEq/L
   147 mEq/L
   40.8 %
   12.1 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
   WBC
   13.2
   12.1
   Hct
   43.3
   40.8
   Plt
   286
   240
   Cr
   0.9
   0.9
   Glucose
   135
   149
   Other labs: PT / PTT / INR:14.5/27.1/1.3, ALT / AST:1747/1377, Alk Phos
   / T Bili:37/0.9, Amylase / Lipase:13/25, Differential-Neuts:90.6 %,
   Lymph:6.5 %, Mono:2.3 %, Eos:0.3 %, Albumin:4.9 g/dL, LDH:1370 IU/L,
   Ca++:9.1 mg/dL, Mg++:2.2 mg/dL, PO4:3.0 mg/dL
   Assessment and Plan
 ANXIETY
 HEPATITIS, ACUTE TOXIC (INCLUDING ALCOHOLIC, ACETAMINOPHEN, ETC.)
 POISONING / OVERDOSE, OTHER
   mushroom ingestion poisoning
 IMPAIRED HEALTH MAINTENANCE
 LIVER FUNCTION ABNORMALITIES
 TACHYCARDIA, OTHER
   45 yo man with evolving liver failure, acute hepatitis due to amanita
   mushroom poisoning.  Rising transaminases, not frankly coagulopathic
   yet - potential.
   -high dose PCN
   -Hepatology, liver transplant teams following - liver tx work-up
   -Continue aggressive hydration
   -Continue NAC
   -Activated charcoal D/C's due to diarrhea
   -po milk thistle (silybum)
   -Cimetidine
   -Cont to follow LFTs, coags, renal function frequently
   Remainder of issues per ICU team
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 32 minutes
   Patient is critically ill
","Based on the provided progress note, the patient is a 45-year-old man with evolving liver failure secondary to mushroom ingestion. The patient presented with diarrhea overnight and nausea. 

The patient has been admitted to the ICU and is critically ill. The patient's vital signs include a temperature of 37.3°C (99.2°F), heart rate of 97 bpm, blood pressure of 142/85 mmHg, respiratory rate of 17 breaths per minute, and oxygen saturation of 96% on nasal cannula. 

The patient's laboratory results show elevated levels of white blood cells, hematocrit, platelets, creatinine, liver enzymes (ALT and AST), lactate dehydrogenase, and bilirubin. The patient also has low levels of albumin and electrolytes such as potassium and sodium.

The patient has been started on aggressive hydration, N-acetylcysteine (NAC), activated charcoal, cimetidine, and milk thistle. The patient is being closely monitored for liver function tests, coagulation profile, and renal function.

Potential medical complications that can arise include worsening liver failure, development of coagulopathy, renal dysfunction, sepsis, and multiorgan failure. The patient's condition requires close monitoring and management by the ICU team, including hepatology and liver transplant teams."
155427.0,246871,2117-11-27 07:42:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - IV silibunin started, d/c'd PCN and cimetidine
   - continuek NAC
   - transplant w/u
     - ECHO: LVEF >55%, mild dilation LA and coronary sinus, otherwise
   normal
     - got CT and u/s Abd, CXR
     - labs per liver
   - PICC placed but unclear location, pulled back to midline
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 05:16 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2117-11-27**] 07:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37.3
C (99.2
   HR: 95 (66 - 118) bpm
   BP: 133/78(91) {120/64(78) - 159/92(107)} mmHg
   RR: 26 (0 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  9,099 mL
                                                                  1,663 mL
   PO:
                                                                    480 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  8,619 mL
                                                                  1,183 mL
   Blood products:
   Total out:
                                                                  4,700 mL
                                                                    200 mL
   Urine:
                                                                  3,050 mL
                                                                    200 mL
   NG:
   Stool:
                                                                  1,650 mL
   Drains:
   Balance:
                                                                  4,399 mL
                                                                  1,463 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///23/
   Physical Examination
   NAD, awake, comfortable
   RRR, cta b/l
   Mild ttp RUQ
   2+ pulses, no peripheral edema
   Labs / Radiology
   156 K/uL
   11.7 g/dL
   119 mg/dL
   0.7 mg/dL
   23 mEq/L
   3.1 mEq/L
   7 mg/dL
   107 mEq/L
   140 mEq/L
   33.5 %
   7.2 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
                            [**2117-11-26**]  10:42 AM
                            [**2117-11-26**]  05:30 PM
                            [**2117-11-26**]  09:06 PM
                            [**2117-11-27**]  01:28 AM
                            [**2117-11-27**]  05:30 AM
   WBC
   13.2
   12.1
   7.2
   Hct
   43.3
   40.8
   33.5
   Plt
   286
   240
   156
   Cr
   0.9
   0.9
   0.8
   0.7
   0.8
   0.7
   0.7
   Glucose
   135
   149
   119
   Other labs: PT / PTT / INR:14.8/29.2/1.3, ALT / AST:3854/2204, Alk Phos
   / T Bili:35/1.5, Amylase / Lipase:13/25, Differential-Neuts:78.4 %,
   Lymph:15.9 %, Mono:3.0 %, Eos:2.2 %, Albumin:3.7 g/dL, LDH:974 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.8 mg/dL, PO4:2.0 mg/dL
   Imaging: Abd u/s:  Echogenic liver, likely reflecting preexisting fatty
   liver disease. patent
   hepatic, portal veins and hepatic arteries with appropriate direction
   of flow.
   CT ABD: pending
   Assessment and Plan
   45 yo M with h/o HTN, HL, presents with N/V/D and LFT abnormalities
   after mushroom ingestion.
   .
   #. Mushroom ingestion:  Pt with rapidly rising LFTs, now trending
   down.  Currently undergoing evaluation for liver transplant.    IV
   silibunin started, PCN and cimetidine d/c
d.  NAC continued in stage 3
   of protocol.
   - NAC
 continue stage 3 in protocol until otherwise advised by
   liver/tox
   - continue  IV silibunin
   - f/u toxicology recs, appreciate input, particularly regarding course
   of high dose medications, inform pharmacy so they are able to obtain
   enough medication.
   - f/u Liver
   - Pretranplant workup started
   - continue LFTs [**Hospital1 7**] until trend established
   #. Tachycardia/Hypertension: improved
   - IVF
   - consider restarting home medication if hypertension becoming
   concerning
   # FEN: advance diet as tolerated, lytes prn, IVF fluids
   # PPX:
   -DVT ppx with heparin SC
   -Bowel regimen - having active diarrhea
   -Pain management with none
   - Antiemetics prn
   -FI with H2Blocker
   .
   # ACCESS: PIV's, Obtain PICC
   .
   # CODE STATUS: confirmed full
   .
   # EMERGENCY CONTACT: wife
   .
   # DISPOSITION: call out to floor
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   PICC Line - [**2117-11-26**] 11:53 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary of Progress Note:
- The patient is a 45-year-old male with a history of hypertension and hyperlipidemia.
- He presented with nausea, vomiting, diarrhea, and liver function test abnormalities after mushroom ingestion.
- Initial assessment revealed tachycardia and hypertension.
- The patient has been started on IV silibinin, N-acetylcysteine (NAC), and is undergoing evaluation for a potential liver transplant.
- Imaging studies, including an echocardiogram, CT scan, and abdominal ultrasound, have been conducted.
- The patient's vital signs are stable with a temperature of 37.3°C, heart rate of 95 bpm, blood pressure ranging from 120/64 to 159/92 mmHg, respiratory rate of 26 breaths per minute, and oxygen saturation of 96%.
- Fluid balance shows an intake of 9,099 mL and output of 4,700 mL, with positive fluid balance of 4,399 mL.
- The patient's blood work reveals elevated white blood cell count, hemoglobin, and platelets, but decreased hematocrit.
- Liver enzymes are significantly elevated, while electrolytes are within normal range.
- Imaging shows an echogenic liver consistent with preexisting fatty liver disease.
- The patient is currently on stage 3 of the NAC protocol and is being monitored for toxicology recommendations.
- Assessment and plan include continuing IV silibinin, f/u toxicology recs, pretransplant workup started, and following up on liver function tests.
- Other concerns addressed include tachycardia/hypertension, advancing diet as tolerated, pain management, and prophylaxis for deep vein thrombosis.

Potential Medical Complications:
Based on the information provided, potential medical complications that could arise include:
1. Acute liver failure: The patient's symptoms and elevated liver enzymes suggest possible acute liver failure due to mushroom ingestion. This condition requires immediate medical attention and may require a liver transplant.
2. Infection: The patient's immunocompromised state due to liver dysfunction increases the risk of infections. Prophylactic measures such as stress ulcer prophylaxis and deep vein thrombosis prophylaxis are already being implemented.
3. Renal dysfunction: Close monitoring of renal function is necessary due to the possibility of renal impairment associated with liver dysfunction.
4. Fluid imbalance: The positive fluid balance indicates the need for careful management of fluid intake and output to prevent fluid overload or dehydration.
5. Hypotension: The patient's blood pressure readings indicate episodes of hypotension, which need to be closely monitored and managed appropriately.
6. Pulmonary complications: The patient's respiratory rate is slightly elevated, and there is a risk of pulmonary complications such as ventilator-associated pneumonia.
7. Bleeding tendencies: Elevated liver enzymes may indicate impaired liver function, leading to decreased synthesis of clotting factors and an increased risk of bleeding.
8. Cardiovascular complications:"
155427.0,246871,2117-11-27 07:42:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - IV silibunin started, d/c'd PCN and cimetidine
   - continuek NAC
   - transplant w/u
     - ECHO: LVEF >55%, mild dilation LA and coronary sinus, otherwise
   normal
     - got CT and u/s Abd, CXR
     - labs per liver
   - PICC placed but unclear location, pulled back to midline
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 05:16 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2117-11-27**] 07:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37.3
C (99.2
   HR: 95 (66 - 118) bpm
   BP: 133/78(91) {120/64(78) - 159/92(107)} mmHg
   RR: 26 (0 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  9,099 mL
                                                                  1,663 mL
   PO:
                                                                    480 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  8,619 mL
                                                                  1,183 mL
   Blood products:
   Total out:
                                                                  4,700 mL
                                                                    200 mL
   Urine:
                                                                  3,050 mL
                                                                    200 mL
   NG:
   Stool:
                                                                  1,650 mL
   Drains:
   Balance:
                                                                  4,399 mL
                                                                  1,463 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///23/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   156 K/uL
   11.7 g/dL
   119 mg/dL
   0.7 mg/dL
   23 mEq/L
   3.1 mEq/L
   7 mg/dL
   107 mEq/L
   140 mEq/L
   33.5 %
   7.2 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
                            [**2117-11-26**]  10:42 AM
                            [**2117-11-26**]  05:30 PM
                            [**2117-11-26**]  09:06 PM
                            [**2117-11-27**]  01:28 AM
                            [**2117-11-27**]  05:30 AM
   WBC
   13.2
   12.1
   7.2
   Hct
   43.3
   40.8
   33.5
   Plt
   286
   240
   156
   Cr
   0.9
   0.9
   0.8
   0.7
   0.8
   0.7
   0.7
   Glucose
   135
   149
   119
   Other labs: PT / PTT / INR:14.8/29.2/1.3, ALT / AST:3854/2204, Alk Phos
   / T Bili:35/1.5, Amylase / Lipase:13/25, Differential-Neuts:78.4 %,
   Lymph:15.9 %, Mono:3.0 %, Eos:2.2 %, Albumin:3.7 g/dL, LDH:974 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.8 mg/dL, PO4:2.0 mg/dL
   Imaging: Abd u/s:  Echogenic liver, likely reflecting preexisting fatty
   liver disease. patent
   hepatic, portal veins and hepatic arteries with appropriate direction
   of flow.
   CT ABD: pending
   Assessment and Plan
   45 yo M with h/o HTN, HL, presents with N/V/D and LFT abnormalities
   after mushroom ingestion.
   .
   #. Mushroom ingestion:  Pt with rapidly rising LFTs, now trending
   down.  Currently undergoing evaluation for liver transplant.    IV
   silibunin started, PCN and cimetidine d/c
d.  NAC continued in stage 3
   of protocol.
   - NAC
 continue stage 3 in protocol until otherwise advised by
   liver/tox
   - continue  IV silibunin
   - f/u toxicology recs, appreciate input, particularly regarding course
   of high dose medications, inform pharmacy so they are able to obtain
   enough medication.
   - f/u Liver
   - Pretranplant workup started
   - continue LFTs q4 until trend established
   #. Tachycardia/Hypertension: improved
   - IVF
   - consider restarting home medication if hypertension becoming
   concerning
   # FEN: NPO for now, lytes prn, IVF fluids
   # PPX:
   -DVT ppx with heparin SC
   -Bowel regimen - having active diarrhea
   -Pain management with none
   - Antiemetics prn
   -FI with H2Blocker
   .
   # ACCESS: PIV's, Obtain PICC
   .
   # CODE STATUS: confirmed full
   .
   # EMERGENCY CONTACT: wife
   .
   # DISPOSITION: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   PICC Line - [**2117-11-26**] 11:53 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Summary:
The patient is a 45-year-old male with a history of hypertension and hyperlipidemia who presented with nausea, vomiting, diarrhea, and abnormal liver function tests after mushroom ingestion. The patient has been admitted to the ICU for close monitoring and treatment. The patient's vital signs are stable with a temperature of 37.3°C, heart rate of 95 bpm, blood pressure ranging from 120-159/64-92 mmHg, respiratory rate of 26 breaths per minute, and oxygen saturation of 96%. The patient has received IV silibunin, discontinued penicillin and cimetidine, and continued N-acetylcysteine (NAC) in stage 3 of the protocol. The patient's blood work shows elevated liver enzymes and an elevated white blood cell count. Imaging studies reveal an echogenic liver suggestive of preexisting fatty liver disease, patent hepatic, portal veins, and hepatic arteries. The patient is currently undergoing evaluation for a liver transplant. 

Potential Medical Complications:
Based on the information provided, potential medical complications that can arise include:
1. Liver failure: The patient has abnormal liver function tests and is being evaluated for a liver transplant, indicating possible liver failure due to mushroom ingestion.
2. Infection: The elevated white blood cell count may suggest an ongoing infection, which could be a concern in the ICU setting.
3. Deep vein thrombosis (DVT): The patient is receiving DVT proph"
155427.0,246871,2117-11-27 07:42:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - IV silibunin started, d/c'd PCN and cimetidine
   - continuek NAC
   - transplant w/u
     - ECHO: LVEF >55%, mild dilation LA and coronary sinus, otherwise
   normal
     - got CT and u/s Abd, CXR
     - labs per liver
   - PICC placed but unclear location, pulled back to midline
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 05:16 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2117-11-27**] 07:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37.3
C (99.2
   HR: 95 (66 - 118) bpm
   BP: 133/78(91) {120/64(78) - 159/92(107)} mmHg
   RR: 26 (0 - 26) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  9,099 mL
                                                                  1,663 mL
   PO:
                                                                    480 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  8,619 mL
                                                                  1,183 mL
   Blood products:
   Total out:
                                                                  4,700 mL
                                                                    200 mL
   Urine:
                                                                  3,050 mL
                                                                    200 mL
   NG:
   Stool:
                                                                  1,650 mL
   Drains:
   Balance:
                                                                  4,399 mL
                                                                  1,463 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///23/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   156 K/uL
   11.7 g/dL
   119 mg/dL
   0.7 mg/dL
   23 mEq/L
   3.1 mEq/L
   7 mg/dL
   107 mEq/L
   140 mEq/L
   33.5 %
   7.2 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
                            [**2117-11-26**]  10:42 AM
                            [**2117-11-26**]  05:30 PM
                            [**2117-11-26**]  09:06 PM
                            [**2117-11-27**]  01:28 AM
                            [**2117-11-27**]  05:30 AM
   WBC
   13.2
   12.1
   7.2
   Hct
   43.3
   40.8
   33.5
   Plt
   286
   240
   156
   Cr
   0.9
   0.9
   0.8
   0.7
   0.8
   0.7
   0.7
   Glucose
   135
   149
   119
   Other labs: PT / PTT / INR:14.8/29.2/1.3, ALT / AST:3854/2204, Alk Phos
   / T Bili:35/1.5, Amylase / Lipase:13/25, Differential-Neuts:78.4 %,
   Lymph:15.9 %, Mono:3.0 %, Eos:2.2 %, Albumin:3.7 g/dL, LDH:974 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.8 mg/dL, PO4:2.0 mg/dL
   Imaging: Abd u/s:  Echogenic liver, likely reflecting preexisting fatty
   liver disease. patent
   hepatic, portal veins and hepatic arteries with appropriate direction
   of flow.
   CT ABD: pending
   Assessment and Plan
   Mushrooms
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   PICC Line - [**2117-11-26**] 11:53 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","Based on the provided information, the patient is currently admitted to the ICU and has been receiving various treatments and interventions. The patient's vital signs are relatively stable, with a temperature of 37.3°C, heart rate of 95 bpm, blood pressure ranging from 120/64 mmHg to 159/92 mmHg, respiratory rate of 26 breaths per minute, and oxygen saturation of 96%. The patient's heart rhythm is in sinus rhythm.

The patient has undergone several tests and procedures, including an echocardiogram showing a left ventricular ejection fraction (LVEF) greater than 55% with mild dilation of the left atrium and coronary sinus. The patient also had a CT scan and abdominal ultrasound, as well as liver function tests.

In terms of lab results, the patient's white blood cell count has been fluctuating between 7.2 and 13.2 thousand cells per microliter. The hemoglobin level is 40.8 g/dL, platelet count is 240 thousand cells per microliter, and creatinine level is 0.9 mg/dL. Blood glucose levels have been ranging from 119 to 149 mg/dL. Other lab results include elevated liver enzymes (ALT and AST), elevated lactate dehydrogenase (LDH), low albumin level, and abnormal electrolyte levels (sodium, potassium, calcium, magnesium, and phosphate).

Imaging studies show an ech"
155427.0,246871,2117-11-27 10:25:00,Physician ,Physician Attending Progress Note,"Chief Complaint: mushroom ingestion
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Feeling better - mentally more clea. No abd pain. Feels stronger
   24 Hour Events:
 EKG - At [**2117-11-26**] 10:30 AM
 TRANSTHORACIC ECHO - At [**2117-11-26**] 11:45 AM
 PICC LINE - START [**2117-11-26**] 11:53 AM
   History obtained from [**Hospital 15**] Medical records
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Penicillin G potassium - [**2117-11-26**] 05:16 PM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2117-11-27**] 09:01 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever, No(t) Weight loss
   Eyes: No(t)  Blurry vision, No(t) Conjunctival edema
   Ear, Nose, Throat: No(t) Dry mouth, No(t) Epistaxis, No(t) OG / NG
   tube, + appetite
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Edema,
   No(t) Tachycardia, No(t) Orthopnea
   Nutritional Support: No(t) NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea, No(t) Wheeze
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   No(t) Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria, No(t) Foley
   Musculoskeletal: No(t) Joint pain, No(t) Myalgias
   Integumentary (skin): No(t) Jaundice
   Endocrine: No(t) Hyperglycemia
   Heme / Lymph: No(t) Lymphadenopathy, No(t) Coagulopathy
   Neurologic: No(t) Numbness / tingling, No(t) Headache
   Psychiatric / Sleep: alert, feels well
   Allergy / Immunology: No(t) Immunocompromised, No(t) Influenza vaccine
   Signs or concerns for abuse : No
   Flowsheet Data as of  [**2117-11-27**] 10:25 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 37
C (98.6
   HR: 69 (66 - 107) bpm
   BP: 125/77(88) {120/64(78) - 150/92(107)} mmHg
   RR: 16 (0 - 26) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 69 Inch
             Total In:
                                                                  9,099 mL
                                                                  2,242 mL
   PO:
                                                                    480 mL
                                                                    720 mL
   TF:
   IVF:
                                                                  8,619 mL
                                                                  1,522 mL
   Blood products:
   Total out:
                                                                  4,700 mL
                                                                    200 mL
   Urine:
                                                                  3,050 mL
                                                                    200 mL
   NG:
   Stool:
                                                                  1,650 mL
   Drains:
   Balance:
                                                                  4,399 mL
                                                                  2,042 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 98%
   ABG: ///23/
   Physical Examination
   General Appearance: Well nourished, No(t) No acute distress, Overweight
   / Obese, No(t) Thin, No(t) Anxious, No(t) Diaphoretic
   Eyes / Conjunctiva: PERRL, w/o icterus
   Head, Ears, Nose, Throat: Normocephalic
   Lymphatic: Cervical WNL
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Not assessed), (Left DP pulse: Not assessed)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical),
   (Percussion: Resonant : ), (Breath Sounds: Clear : , No(t) Crackles : ,
   No(t) Wheezes : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent, No(t) Cyanosis, No(t) Clubbing
   Musculoskeletal: No(t) Muscle wasting, No(t) Unable to stand
   Skin:  Warm, No(t) Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Oriented (to): x3, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   11.7 g/dL
   156 K/uL
   119 mg/dL
   0.7 mg/dL
   23 mEq/L
   3.1 mEq/L
   7 mg/dL
   107 mEq/L
   140 mEq/L
   33.5 %
   7.2 K/uL
        [image002.jpg]
                            [**2117-11-25**]  10:07 PM
                            [**2117-11-26**]  02:30 AM
                            [**2117-11-26**]  10:42 AM
                            [**2117-11-26**]  05:30 PM
                            [**2117-11-26**]  09:06 PM
                            [**2117-11-27**]  01:28 AM
                            [**2117-11-27**]  05:30 AM
   WBC
   13.2
   12.1
   7.2
   Hct
   43.3
   40.8
   33.5
   Plt
   286
   240
   156
   Cr
   0.9
   0.9
   0.8
   0.7
   0.8
   0.7
   0.7
   Glucose
   135
   149
   119
   Other labs: PT / PTT / INR:14.8/29.2/1.3, ALT / AST:3393/1540, Alk Phos
   / T Bili:35/1.5, Amylase / Lipase:13/25, Differential-Neuts:78.4 %,
   Lymph:15.9 %, Mono:3.0 %, Eos:2.2 %, Albumin:3.7 g/dL, LDH:974 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.8 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
 ANXIETY
 HEPATITIS, ACUTE TOXIC (INCLUDING ALCOHOLIC, ACETAMINOPHEN, ETC.)
 POISONING / OVERDOSE, OTHER
   mushroom ingestion poisoning
 IMPAIRED HEALTH MAINTENANCE
 LIVER FUNCTION ABNORMALITIES
 TACHYCARDIA, OTHER
   LFTs appear to be peaking and now declinig.  Unclear if this is a
   response to milk thistle or if this is simply a mild toxic ingestion.
   In any case will continue infusion until LFTs have returned to [**Location 810**].
   Needs continued close observation over next several days with
   monitoring of transaminases and INR.  HR has improved and remains
   afebrile.  Will transfer to liver service.
   Plt ct is declining. Will review all meds. Unlikely to be a consequence
   of toxic ingestion.  Would seem early for heparin.
   ICU Care
   Nutrition:
   Comments: Starting regular diet
   Glycemic Control:  Comments: none needed
   Lines:
   20 Gauge - [**2117-11-25**] 12:06 PM
   18 Gauge - [**2117-11-25**] 12:28 PM
   PICC Line - [**2117-11-26**] 11:53 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , ICU
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 40 minutes
","Based on the provided information, the patient's chief complaint is mushroom ingestion. The patient is in the ICU and has shown improvement in their mental clarity and overall well-being. 

The patient's vital signs are stable, with a temperature of 37.3°C (99.2°F), blood pressure ranging from 120-150/64-92 mmHg, heart rate between 66-107 bpm, respiratory rate of 16 breaths per minute, and oxygen saturation at 98%. The patient's heart rhythm is sinus rhythm.

The patient's physical examination reveals no acute distress, normal cardiovascular and respiratory findings, no edema in the lower extremities, and no abnormal neurological findings.

Laboratory results show elevated liver enzymes (AST and ALT), indicating possible liver injury. Other lab results are within normal limits.

The assessment and plan include anxiety, acute toxic hepatitis, poisoning/overdose, mushroom ingestion poisoning, impaired health maintenance, liver function abnormalities, and tachycardia. The liver function tests (LFTs) appear to be peaking and now declining, possibly in response to milk thistle or a mild toxic ingestion. The patient will continue with an infusion until the LFTs return to normal. Close observation is required over the next several days with monitoring of transaminases and INR.

The patient's platelet count is declining, which may not be related to the toxic ingestion. The patient's condition will be reviewed, and all medications will be evaluated"
